Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBoston Int Regulatory News (BIH)

  • This share is currently suspended. It was suspended at a price of 0.598

Share Price Information for Boston Int (BIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.598
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.598
BIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

26 Sep 2022 07:00

RNS Number : 5103A
Boston International Holdings PLC
26 September 2022
 

Boston International Holdings plc

("BIH" or "the Company")

 

 26 September 2022

 

 

UNAUDITED HALF YEAR REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2022

 

 

Boston International Holdings plc, formed in November 2015, which operates as a special purpose acquisitions company (SPAC) to undertake one or more acquisitions of target companies or businesses, announces its unaudited half year report for the six months ended 30 June 2022.

 

Chairman's Statement

 

I have pleasure in presenting the interim results of Boston International Holdings Plc for the six months ended 30 June 2022.

 

During the financial period under review, the Company reported a net loss of £268,877, being the administrative expenses incurred. As at 30 June 2022 the Company had cash in bank balance of £182,000. 

 

During the period under review the Directors have continued to actively review potential acquisition opportunities for the Company expanding its search for an appropriate acquisition target

 

A further announcement will be made at such time as the Company is able to provide further details on any proposed transaction.

 

Christopher Pitman

Chairman

 

 

Interim Management Report

 

Company Objective

 

The Company was originally formed to undertake an acquisition of a target company or business in the foreign exchange (FX) sector, however due to a lack of current opportunities in that sector, following the general meeting held on 6 September 2019 the Directors' efforts in identifying a prospective target company or business are no longer limited to a particular industry or geographic region.

 

There is no specific expected target value for the acquisition and the Company expects that any funds not used for the acquisition will be used for future acquisitions, internal or external growth and expansion, and working capital in relation to the acquired company or business.

 

Following completion of an acquisition, the objective of the Company will be to operate the acquired business and implement an operating strategy with a view to generating value for its shareholders through operational improvements as well as potentially through additional complementary acquisitions following the acquisition.

 

Key Events

 

On 7 March 2022 the Company announced that the Final Repayment Date in respect of the £125,714 nominal Zero Coupon Convertible Unsecured Loan Notes 2022 issued by the Company on 12 April 2021 has been extended from 31 March 2022 to 30 September 2022. All other terms of the Convertible Loan Notes remain unchanged from the terms announced by the Company on issue.

On 12 April 2022 the Company announced that the terms of the existing £125,714 convertible loan notes issued on 12 April 2021 and the existing £251,000 convertible loan notes issued on 7 July 2021 have been varied such that the final repayment date has been extended from 30 September 2022 to 30 September 2023; and the conversion provisions (at a price of 1 pence per ordinary share into ordinary shares of 1 pence each in the Company) have been amended so that they are now convertible into ordinary shares at any time, with the written consent of the Company at any time prior to the 'Final Repayment Date' and will now automatically be converted at the earlier of the publication of a prospectus or the completion of a 'reverse takeover' transaction and admission of the Company's share capital to trading on a recognised stock exchange. The Company further announced that, following the variation of the Existing Convertible Loan Notes the aggregate £295,714 principal of Existing Convertible Loan Notes held by Borden James, a Director of BIH (following the transfer of £95,714 of such Convertible Loan Notes to him by Boston Merchant (HK) Limited, a company 98.04% owned by him) have been converted into 29,571,400 new ordinary shares of 1p each in the Company at a conversion price of 1p per share, allotted and issued to Borden James.

 

On 22 April 2022 the Company announced the placing of 18,703,307 new ordinary shares at price of 1 pence per share to raise £187,033. As part of the Placing, Borden James, a Director of the Company, instructed the Company to allot and issue the 29,571,400 Ordinary Shares allotted and issued to him. These 29,571,400 shares were immediately placed in the market and the £147,857 proceeds received by Mr James have simultaneously been reinvested back into the Company, via the issue to Mr James by BIH of a New Convertible Loan Note. The New Convertible Loan Notes will have the same terms as the Existing Convertible Loan Notes (as referred to and varied as stated in the announcement by the Company on 12 April 2022), save as regards conversion. Following the Placing, Borden James holds no Ordinary Shares in the Company.

On 20 May 2022 the Company announced that shareholders had approved at a General Meeting a resolution to effect a share capital reorganisation (sub-dividing and converting each ordinary share of 1 pence in the capital of the Company into one ordinary share of 0.1 pence and one deferred share of 0.9 pence).

 

Principal Risks and Uncertainties

 

The Company is subject to a number of risk factors. The Directors have identified the following key risks in the second six months of this financial year. Other risk factors not presently known or currently deemed immaterial may also apply.

· The Company is dependent on its directors, in particular the Chairman, to manage the Company and its future strategy. If the Company were to lose the services of the Chairman, it could have a material adverse effect on the Company and its ability to implement its future strategy.

Whilst it continues its assessment of potential acquisition opportunities, the Board will continue to prudently manage the Company's remaining cash reserves and minimise its operating expenses in order to put the Company in the best position possible to complete an acquisition.

Related Parties Transactions

On 22 April 2022 as part of the financial arrangements set out above, Mr James, a Director of the Company, invested £147,857 into New Convertible Loan Notes. Mr James holds no Ordinary Shares in the Company. 

Responsibility Statement

 

The Directors are responsible for preparing the Interim Report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority ('DTR') and with International Accounting Standard 34 on Interim Financial Reporting (IAS 34).

 

The Directors (all non-executive) being Christopher Pitman, Martin Lampshire, W Borden James and Richard Hartheimer confirm that to the best of their knowledge:

 

· the interim financial statements, prepared in accordance with the applicable set of accounting standards, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company; and

 

· the interim financial statements have been prepared in accordance with IAS 34 and that as required by DTR 4.2.7 and DTR 4.2.8, the Interim Report gives a fair review of:

 

- important events that have occurred during the first six months of the year;

- the impact of those events on the financial statements;

- a description of the principal risks and uncertainties for the remaining six months of the financial year; 

- details of any related party transactions that have materially affected the Company's financial position or performance in the six months ended 30 June 2021; and

- any changes in the related parties transactions described in the last annual report that could have a material effect on the financial position or performance of the enterprise in the first six months of the current financial year.

 

By order of the Board

 

 

Christopher Pitman

Chairman

 

23 September 2022

 

   

 

Boston International Holdings plc 

Condensed Statement of Comprehensive Income

 

 

Six months

Six months

12 months

30 June

30 June

31 December

2022

2021

2021

Note

Unaudited

Unaudited

Audited

£000

£000

£000

Revenue

 

-

-

-

Administrative expenses

(279)

(187)

(418)

Operating loss

 

(279)

(187)

(418)

Finance income/(expense)

10

-

(16)

Loss on ordinary activities before taxation

 

(269)

(187)

(434)

Income tax expense

-

-

-

Loss after taxation

 

(269)

(187)

(434)

Other comprehensive income

 

-

-

-

Total comprehensive income attributable to

 

(269)

(187)

(434)

owners of the parent

 

Earnings per share (EPS):

 

Basic and diluted(pence)

 

3

(0.32)

(0.46)

(0.84)

 

 

Boston International Holdings plc 

Condensed Statement of Financial Position as at 30 June 2022

 

6 months

6 months

12 months

30 June

30 June

31 December

2022

2021

2021

Note

Unaudited

Unaudited

Audited

£000

£000

£000

Current assets

 

Other receivables and prepayments

19

17

32

Cash and bank balances

182

100

65

Total Assets

 

201

117

97

Current Liabilities

 

Unsecured Loan

-

(200)

-

Convertible Loan Notes

-

(126)

(356)

Other payables and accruals

(83)

(78)

(35)

Total current liabilities

(83)

(404)

(391)

Liabilities due in more than 12 months

 

Convertible Loan Notes

(203)

-

-

Total liabilities due in more than 12 months

 

(203)

-

-

Total Liabilities

 

(286)

(404)

(391)

Net Assets/(Liabilities)

 

(85)

(287)

(294)

Equity

 

Share capital

4

1,122

439

639

Share premium

1,318

1,318

1,318

Other reserves

35

-

40

Reserves

(2,560)

(2,044)

(2,291)

(287)

(287)

173

Total Equity and Liabilities

 

(85)

(287)

(294)

Boston International Holdings plc

Condensed Statement of Changes in Equity

For the six month period ended 30 June 2022 (Unaudited)

 

Share

Share

Other

Retained

Total

capital

premium

reserves

profits

equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 January 2021

366

1,318

-

(1,857)

(173)

Issue of shares

73

-

-

-

73

Loss for the period

-

-

-

(187)

(187)

Balance at 30 June 2021

439

1,318

0

(2,044)

(287)

Issue of shares

200

-

-

-

200

Loss for the period

-

-

-

(247)

(247)

Convertible Loan Notes-

equity element

-

-

40

-

40

Balance at 31 December 2021

639

1,318

40

(2,291)

(294)

Issue of shares

483

483

Loss for the period

(269)

(269)

Convertible Loan Notes-

equity element

(5)

(5)

Balance at 30 June 2022

1,122

1,318

35

(2,560)

(85)

 

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Boston International Holdings plc

Condensed Statements of Cash Flows

For the six-month period ended 30 June 2022

 

 

6 months

6 months

12 months

30 June

30 June

31 December

2022

2021

2021

Note

Unaudited

Unaudited

Audited

£000

£000

£000

Cash flow from operating activities

 

Loss before taxation

(269)

(187)

(434)

Adjustment for:

 

Interest income/(expense)

(10)

-

16

Operating cash flows before movements in working capital

(279)

(187)

(418)

Decease/(increase) in trade and other receivables

 

12

(7)

(21)

Decrease/(increase) in trade and other payables

49

22

(22)

Cash generated from operations

61

15

(43)

Cash flows from operating activities

 

(218)

(172)

(461)

Proceeds from share issue

483

73

273

Convertible Loan Notes

(158)

126

396

Unsecured loan

-

 (200)

Net cash generated from financing activities

325

199

469

Cash flows from investing activities

 

Interest received/(expenses)

10

-

(16)

Net cash generated from investing activities

10

-

(16)

Net Increase/(decrease) in cash & cash equivalents

117

27

(8)

Cash and equivalent at beginning of the period

65

73

73

Cash and equivalent at end of the period

 

182

100

65

 

Boston International Holdings plc

 

NOTES TO THE FINANCIAL INFORMATION

 

1. GENERAL INFORMATION AND PRINCIPAL ACTIVITIES

 

The Company is incorporated in England and Wales as a public limited company with company number 09876705. The registered office of the Company is 5 Chancery Lane, London WC2A 1LG.

 

This financial information is for the Company only as there are no subsidiary undertakings.

 

The principal place of business of the Company is in the United Kingdom.

 

The interim financial statements are presented in the nearest thousands of Pound Sterling (£'000), which is the presentation currency of the company.

 

 

2. BASIS OF PREPARATION

 

The interim financial statements for the six months ended 30 June 2022 have been prepared in accordance with IAS 34, Interim Financial Reporting.

 

The principal accounting policies used in preparing the interim results are the same as those applied in the Company's Financial Statements as at and for the period ended 31 December 2021.

 

A copy of the audited financial statements for the period ended 31 December 2021, which was prepared under IFRS, is available on the Company's website.

 

The interim report for the six months ended 30 June 2022 was approved by the Directors on xx September 2022.

 

 

3. EARNINGS PER SHARE

 

The earnings per share information is as follows:

 

 

Six months

Six months

12 months

30 June

30 June

31 December

2022

2021

2021

Unaudited

Unaudited

Audited

(Loss) after taxation (Pound £)

(268,877)

(187,159)

(434,323)

Weighted average number of ordinary shares

82,614,914

40,343,740

51,857,869

Basic earnings per share (pence)

(0.32)

(0.46)

(0.84)

The diluted earnings per share was not applicable as there were no dilutive potential ordinary shares outstanding at the end of the reporting period. IAS33 requires presentation of diluted EPS when a company could be called upon to issue shares that decrease earnings per share or increase the loss per share. For a loss-making company with outstanding share options or warrants, net loss per share would be decreased by exercise of options. Therefore, per IAS33.36 the antidilutive potential ordinary shares are disregarded in the calculation of diluted EPS

 

  

 

 

4. Share Capital

 

Number

of shares

 

£'000

Issued:

As at 1 January 2022

63,945,137

639

Issue of shares

 

48,274,707

483

As at 30 June 2022

112,219,844

1,122

 

 

 

 

 

5. RELATED PARTY TRANSACTIONS

 

Key management are considered to be the directors and the key management received no compensation in the period.

On 22 April 2022 as part of the financial arrangements set out above, Mr James, a Director of the Company, invested £147.857 into New Convertible Loan Notes. Mr James holds no Ordinary Shares in the Company.

 

6. SEASONAL OR CYCLICAL FACTORS

There are no seasonal factors that materially affect the operations of the company.

 

 

7. EVENTS AFTER THE REPORTING DATE

 

There are no reportable events.

 

- ENDS -

This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR").

For further information, please contact:

 

Boston International Holdings Plc

Christopher Pitman, Chairman +44 (0) 20 3735 8825

 

Peterhouse Capital Limited (Broker)

Lucy Williams / Duncan Vasey / Eran Zucker +44 (0) 20 7469 0930

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BUGDCGBDDGDX
Date   Source Headline
3rd Jan 202411:08 amRNSAcquisition Update & New Convertible Loan Notes
5th Oct 20237:00 amRNSHeads of Terms Signed re Potential Acquisition
29th Sep 20237:00 amRNSConvertible Loan Notes Repayment Date Extended
27th Sep 20237:00 amRNSHalf-year Report
26th Jun 202311:40 amRNSIssue of Ordinary Shares to Boston Merchant (HK)
20th Jun 20231:01 pmRNSAnnual Report and Accounts – Replacement
20th Jun 20237:00 amRNSFinal Results
28th Apr 20234:30 pmRNSAnnual Report - Delay in Publication
27th Apr 20235:24 pmRNSPotential RTO of Topic S.A & Suspension of Listing
27th Mar 202312:43 pmRNSAppointment of Auditor
9th Feb 20233:51 pmRNSHolding(s) in Company
7th Feb 20237:30 amRNSHolding(s) in Company
31st Jan 20231:38 pmRNSHolding(s) in Company
31st Jan 20231:37 pmRNSHolding(s) in Company
31st Jan 20231:25 pmRNSHolding(s) in Company
31st Jan 20231:14 pmRNSHolding(s) in Company
31st Jan 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectors' Subscriptions for New Ordinary Shares
23rd Dec 202210:44 amRNSHolding(s) in Company
9th Dec 20222:52 pmRNSResult of 2022 AGM
1st Dec 20226:10 pmRNSTotal Voting Rights
17th Nov 20227:30 amRNSAnnouncement of AGM and PDMR Dealings
11th Nov 202211:30 amRNSHolding(s) in Company
21st Oct 202210:21 amRNSHolding(s) in Company
19th Oct 20223:42 pmRNSHolding(s) in Company
18th Oct 20221:30 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSHalf-year Report
3rd Aug 20222:25 pmRNSHolding(s) in Company
30th Jun 20222:20 pmRNSAnnual Financial Report
25th May 202210:09 amRNSHolding(s) in Company
20th May 20223:45 pmRNSResult of General Meeting
5th May 20229:00 amRNSDirector/PDMR Shareholding
3rd May 202212:36 pmRNSHolding(s) in Company
29th Apr 20225:22 pmRNSTotal Voting Rights
29th Apr 202211:14 amRNSHolding(s) in Company
29th Apr 202210:15 amRNSHolding(s) in Company
29th Apr 202210:14 amRNSHolding(s) in Company
29th Apr 202210:13 amRNSHolding(s) in Company
27th Apr 20225:50 pmRNSPosting of Circular, GM Notice & Issue of New CLN
22nd Apr 20221:46 pmRNSFundraising & Issue of New Convertible Loan Notes
20th Apr 20223:00 pmRNSHolding(s) in Company
12th Apr 202212:20 pmRNSVariation and Partial Conversion of Existing CLN
7th Mar 20227:00 amRNSConvertible Loan Note Repayment Date Extended
31st Jan 20222:46 pmRNSResult of AGM
17th Jan 20222:11 pmRNSAdjournment of Annual General Meeting
7th Jan 20225:57 pmRNSHolding(s) in Company
20th Dec 20217:00 amRNSPosting of Notice of AGM & 2020 Report & Accounts
30th Sep 20217:00 amRNSHalf-year Report
30th Jul 20216:19 pmRNSHolding(s) in Company
30th Jul 202111:50 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.